Skip to main content

Biora Therapeutics, Inc.

BIORDelisted Jun 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001580063

Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Biora Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of BIOR: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders29121−7
Shares12.2M65.1K12.2M+54.2K (+0.4%)
Value$8.07M$42.9K$6.13M−$1.90M (−23.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Biora Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to BIOR in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.61,608$30.9K0.00%
HRT Financial LP33,798$16.0K0.00%
JPMorgan Chase & Co22$110.00%
Avion Wealth1,500$00.00%

Sold out (11)

Institutions that held Biora Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Biora Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BIOR in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.65,051$42.9K